2 recruiting, 2 terminated. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 2, Terminated 2 |
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow Ileal Pouch: new trials by email Literature Review of Ileal Pouch trials Research Report on Ileal Pouch
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation Aquamin - Ulcerative Colitis, Ileal Pouch | Phase 2 | Recruiting | Muhammad N Aslam, MD | 52 | 2026-11-01 | 2026-11-02 |
| Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) EXE-346, Placebo - Ileal Pouch | Phase 1 / Phase 2 | Recruiting | Exegi Pharma, LLC | 50 | 2023-11-06 | 2026-05-28 |
| Tofacitinib For Treatment Of Chronic Pouchitis Tofacitinib 10 mg - Pouchitis, Ileal Pouchitis | Phase 2 | Terminated | Cedars-Sinai Medical Center | 6 | 2021-01-25 | 2024-04-04 |
| Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease Mesenchymal stem cells, Placebo - Ileal Pouch, Crohn Disease | Phase 1 / Phase 2 | Terminated | Anthony Lembo | 24 | 2020-10-28 | 2026-04-16 |
Pouchitis (2) · Colitis, Ulcerative (1) · Crohn Disease (1)
Digestive System Diseases (4) · Gastroenteritis (4) · Gastrointestinal Diseases (4) · Intestinal Diseases (4) · Enteritis (2) · Ileal Diseases (2) · Ileitis (2) · Inflammatory Bowel Diseases (2) · Colitis (1) · Colonic Diseases (1)
Aquamin (1) · tofacitinib (1)
Anthony Lembo (1) · Cedars-Sinai Medical Center (1) · Exegi Pharma, LLC (1) · Muhammad N Aslam, MD (1)
United States (4)
Amy Lightner, MD (1) · Julia Collins, MS (1) · Muhammad N Aslam, MBBS, MD (1)